| Yu, Ming |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 04/25 | | |
| Recruiting | 3 | 2100 | Europe, Canada, Japan, US, RoW | Rimegepant/BHV3000, Matching placebo | Pfizer | Pediatric Migraine | 01/29 | 01/29 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
NCT04264260: Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment |
|
|
| Recruiting | 2 | 80 | RoW | Colchicine Tablets | Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Medical University | Hepatocellular Carcinoma Stage IIIB, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma; With Hepatocellular Carcinoma, Hepatocellular Carcinoma Stage IV | 07/25 | 07/25 | | |
NCT05774873: IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 128 | RoW | IBI334 D, IBI334 C, IBI334 A, IBI334 B, IBI334 F, IBI334 E | Innovent Biologics (Suzhou) Co. Ltd. | Solid Tumors | 10/25 | 06/26 | | |
NCT04104282: the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. |
|
|
| Recruiting | N/A | 240 | RoW | | Xijing Hospital | Non-alcoholic Fatty Liver Disease | 12/25 | 12/25 | | |
NCT05187416: Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer |
|
|
| Recruiting | N/A | 50 | RoW | two-dimensional shear wave elastography | Xijing Hospital | Pancreatic Neoplasms | 10/22 | 10/22 | | |
